1-1 of 1
Authors: Aids Clinical Trials Group Virology Laboratories
Journal Article
Serum p24 Antigen Level as an Intermediate End Point in Clinical Trials of Zidovudine in People Infected with Human Immunodeficiency Virus Type 1 Get access
The Journal of Infectious Diseases, Volume 169, Issue 4, April 1994, Pages 713–721, https://doi.org/10.1093/infdis/169.4.713
Published: 01 April 1994
